Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: J Adolesc Health. 2020 Aug 21;68(6):1104–1111. doi: 10.1016/j.jadohealth.2020.07.033

Table 1.

Demographic Characteristics Based on Designated Sex at Birth

GnRHa Cohort (N=95)
Total Sample Designated Female at Birth Designated Male at Birth t or χ2 (df) p-value
Total n (%) 95 46 (48.4) 49 (51.6)
Age M (SD) 11.22 (1.46) 10.76 (1.43) 11.65 (1.36) 3.11 (93) .002
Gender Identity
 Transmasculine/Male 41 (43.2) 40 (87) 1 (2) + 78.28 (2) 0.000
 Transfeminine/Female 45 (47.4) 1 (2.2) + 44 (89.8)
 Non-binary 9 (9.5) 5 (10.9) 4 (8.2)
Race/Ethnicity
 White 50 (52.6) 31 (67.4) 19 (38.8) 10.01 (5) .075
 Latinx 21 (22.1) 8 (17.4) 13 (26.5)
 Black/African-American 3 (3.2) 1 (2.2) 2 (4.1)
 Multiracial 13 (13.7) 5 (10.9) 8 (16.3)
 Other 4 (4.2) - 4 (8.2)
 Unreported 4 (4.2) 102 3 (6.1)
GAH Cohort (N=316)
Total Sample Designated Female at Birth Designated Male at Birth t or χ2 (df) p-value
Total n (%) 316 205 (64.9) 111 (35.1)
Age M (SD) 16 (1.88) 15.87 (1.76) 16.23 (2.08) 1.57 (195.29) 0.12
Gender Identity
 Transmasculine 191 (60.4) 191 (93.72) - 293.64 (2) 0.000
 Transfeminine/Female 106 (33.5) 1 (0.5) + 105 (94.6)
 Non-binary 19 (6.0) 13 (6.3) 6 (5.4)
Race/Ethnicity
 White 196 (62.0) 127 (62.0) 69 (62.2) 2.17 (4) 0.71
 Latinx 70 (22.2) 49 (23.9) 21 (18.9)
 Black/African-American 14 (4.4) 10 (4.9) 4 (3.6)
 Multiracial 10 (3.2) 5 (2.4) 5 (4.5)
 Other 23 (7.3) 14 (6.8) 9 (8.1)
 Unknown/unreported 3 (0.9) - 3 (2.7)

Note. GnRHa = gonadotropin releasing hormone agonists. GAH = gender-affirming hormones. M = mean; SD = standard deviation

+

Participant’s designated sex at birth was concordant with their reported gender identity at the point of baseline.